Search

Search Constraints

You searched for: Author/Creator Berger, Marc

Search Results

2. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2022)

4. Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: Recommendations for clinical practice from the French Chronic Myeloid Leukemia Study Group. Issue 14 (3rd May 2018)

5. Field testing the ENSEMBLE Minimum Dataset: performance of an instrument to address heterogeneity of treatment effects. (September 2014)

6. Hematologic, immunologic reconstitution, and outcome of 342 autologous peripheral blood stem cell transplantations after cryopreservation in a −80°C mechanical freezer and preserved less than 6 months. Issue 3 (15th July 2012)

7. Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative. Issue 11 (13th September 2020)

8. Mast cell density and its clinical relevance in Waldenström's macroglobulinemia. Issue 2 (8th February 2022)

9. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

10. STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma. (30th April 2015)